Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | B. Solomon, A. Shaw, S. Ou, B. Besse, E. Felip, T. Bauer, R. Soo, A. Bearz, C. Lin, J. Clancy, A. Abbattista, H. Thurm, G. Peltz, E. Masters, J. Martini, L. James, T. Seto | ||||||||||||
Title | Phase 2 Study of Lorlatinib in Patients with Advanced ALK+/ROS1+ Non-Small-Cell Lung Cancer | ||||||||||||
|
|||||||||||||
URL | http://www.jto.org/article/S1556-0864(17)31086-9/abstract | ||||||||||||
Abstract Text | J Thorac Oncol. Nov 2017, 12(11); Suppl 2, S1756, abstract OA 05.06 DOI: https://doi.org/10.1016/j.jtho.2017.09.351 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|